DC4 Investor Relations & Company Overview - Dexcom Inc

Watchlist Manager

Watchlist

Price: 78.2 EUR 4.27% Market Closed

Market Cap: €60.5B

D	Dexcom Inc XMUN:DC4	US
E	Empatho Holdings Inc CNSX:EMPH	CA
	Innovotech Inc XTSX:IOT	CA
M	Mesoblast Ltd OTC:MEOBF	AU
C	Classic Scenic Bhd KLSE:HEXRTL	MY
S	Sun Vending Technology PCL SET:SVT	TH
	Yara International ASA OSE:YAR	NO
C	Charles Schwab Corp BMV:SCHW	US
	Ather Energy Ltd NSE:ATHERENERG	IN
	Scope Industries OTC:SCPJ	US
R	Recupero Etico Sostenibile SpA MIL:RES	IT
	Capstone Copper Corp TSX:CS	CA
C	Coinbase Global Inc BMV:COIN	US
A	Ackermans & Van Haaren NV F:B3K	BE
	Telekom Malaysia Bhd KLSE:TM	MY
	F I P P SA PAR:FIPP	FR
T	Ta Ya Electric Wire & Cable Co Ltd TWSE:1609	TW
S	Source Energy Services Ltd OTC:SCEYF	CA
	Global Menkul Degerler AS IST:GLBMD.E	TR
S	Sri Trang Gloves (Thailand) PCL SET:STGT	TH
	Versus Systems Inc NASDAQ:VS	US
P	Pharmedic Pharmaceutical Medicinal JSC VN:PMC	VN
T	Tai United Holdings Ltd HKEX:718	HK
	HF Company SA PAR:ALHF	FR

Company Overview

Business Description

Sector: Health Care
Industry: Health Care
Headquarters: United States of America US
Employees: 11 000
IPO date: Apr 14, 2005

Dexcom makes continuous glucose monitoring systems for people with diabetes. Its core product is a small wearable sensor that tracks glucose levels through the day and sends readings to a smartphone, receiver, or insulin pump, so users can manage blood sugar without repeated finger sticks. The company also sells the software and connected apps that display trends and alerts.

Its main customers are people with diabetes, along with the doctors, clinics, hospitals, and insurance plans that recommend, prescribe, or reimburse the devices. Dexcom makes money mostly by selling the disposable sensors and other consumables that patients replace regularly, plus related receivers and accessories. That gives the business a recurring revenue pattern rather than a one-time device sale.

What makes Dexcom different is that it sits between medical devices and digital health. It does not just make hardware; it sells an ongoing monitoring service built around data, alerts, and software that help patients and caregivers respond quickly to glucose changes. In the diabetes care chain, Dexcom is a key provider of real-time glucose data used to guide daily treatment decisions.

Dexcom Inc Investor Relations

6340 Sequence Drive

San Diego, California

United States of America

+13026365400 www.dexcom.com

Business Segments

Unlock Business Segments

Continuous glucose monitoring

Dexcom makes continuous glucose monitoring systems that track glucose levels through a sensor worn on the body and send readings to a phone, receiver, or compatible diabetes device. It also sells the sensors, transmitter...

Customers

People with diabetes, as well as doctors, diabetes clinics, and hospitals that recommend or prescribe glucose monitoring products.

Revenue Model

Dexcom mainly earns money by selling the starter devices and then recurring replacement sensors and other disposable supplies, along with related software and connected device sales.